Rachel Cohen is the Regional Executive Director of the North America office of the Drugs for Neglected Diseases initiative (DNDi), an international nonprofit research and development organization that discovers and develops new medicines for several neglected tropical diseases, pediatric HIV, hepatitis C and, through a joint initiative with the World Health Organization, the Global Antibiotic R&D Partnership (GARDP), serious drug-resistant infections.
Prior to joining DNDi in 2011, she worked for Doctors Without Borders/Médecins Sans Frontières (MSF) from 1999-2010. She served as Head of Mission for MSF in South Africa and Lesotho for four years, overseeing numerous medical programs primarily focused on HIV/AIDS and drug-resistant TB. Before working for MSF in the field, she was the US Director of MSF’s Access to Essential Medicines Campaign. From 2009-2015, she served on the Board of Directors of MSF’s Operational Center in Brussels.
Prior to working with MSF, she was the Director of Foundation & Corporate Giving at Housing Works, the largest minority-controlled AIDS service organization in the US, and before that served as Program Coordinator for the US+Cuba Medical Project, where she directed medical aid, educational and advocacy programs.
Cohen earned her master’s degree in Public Policy with a certificate in Health and Health Policy from Princeton University’s Woodrow Wilson School of Public and International Affairs.